2019
DOI: 10.1016/j.vaccine.2019.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 41 publications
0
5
0
Order By: Relevance
“…While a plethora of potential neosporosis vaccine candidates have been evaluated in recent years [35,36], NcSAG1 was chosen as target antigen since it represents a highly immunodominant, surface protein of N. caninum tachyzoites, which is implicated in the host cell invasion process [37,38]. NcSAG1 applied as DNA vaccine and as recombinant antigen [39][40][41][42] had been shown earlier to confer partial protection against cerebral infection in non-pregnant mice.…”
Section: Discussionmentioning
confidence: 99%
“…While a plethora of potential neosporosis vaccine candidates have been evaluated in recent years [35,36], NcSAG1 was chosen as target antigen since it represents a highly immunodominant, surface protein of N. caninum tachyzoites, which is implicated in the host cell invasion process [37,38]. NcSAG1 applied as DNA vaccine and as recombinant antigen [39][40][41][42] had been shown earlier to confer partial protection against cerebral infection in non-pregnant mice.…”
Section: Discussionmentioning
confidence: 99%
“…This result indicates that the 3C proteinase was functionally expressed in silkworm-BEVS. Although we did not continue to purify the GST-3C, we can expect a satisfactory amount of 3C protein from silkworm larvae since scaleup expression can be simply performed by increasing the sample size [ 29 , 35 , 37 ].…”
Section: Resultsmentioning
confidence: 99%
“…For instance, NcSAG1 is constitutively expressed on the tachyzoite surface and is likely to mediate the initial contact between the parasite and the host cell surface membrane. NcSAG1 has been previously assessed as a vaccine candidate by employing different expression systems such as DNA-vaccines and recombinant antigens [ 21 ], the integration of a recombinant antigen into immune-stimulating complexes (ISCOMs) [ 44 ] and expression in silkworm larvae ( Bombyx mori ) using nucleopolyhedrovirus (BmNPV) bacmid expression systems [ 45 ] or Rous sarcoma virus-like particles (RSV-LP) displaying both NcSAG1 and NcSRS2 [ 46 ]. NcROP2 has also been shown earlier to represent a promising vaccine candidate, either alone or in combination with other recombinant antigens [ 38 ].…”
Section: Discussionmentioning
confidence: 99%